Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19

• Autores principales: Valentina Fanny Leone (Autor), Amantia Imeraj (Autor), Sara Gastoldi (Autor), Caterina Mele (Autor), Lucia Liguori (Autor), Carmelita Condemi (Autor), Piero Ruggenenti (Autor), Giuseppe Remuzzi (Autor), Camillo Carrara (Autor)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Hemolytic uremic syndrome (HUS) is a rare life-threatening disease of unrestrained complement system dysregulation, microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure in genetically predisposed individuals. In this report, we describe two cases of SARS-CoV-2-associated HUS...